Olema Pharmaceuticals

Forecast & Rating12 analysts currently cover Olema Pharmaceuticals, with about 91.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $36.50, about 469.4% upside from the current price of $6.41. Price targets range from $16.00 to $59.00 — a wide spread, showing clear disagreement over just how much Olema Pharmaceuticals can rise. Historically, about 48.4% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Olema Pharmaceuticals closely still see room for the stock to rise. Data as of Sep 21, 2026; for reference only and not investment advice.